Introduction
All you need to know about SYMBICORT RAPIHALERª 160/4.5 mcg .
Welcome to Dwaey, specifically on SYMBICORT RAPIHALERª 160/4.5 mcg page.
This medicine contains an important and useful components, as it consists of Budesonide/Formoterol.
SYMBICORT RAPIHALERª 160/4.5 mcg is available in the market in concentration 160/4.5 micrograms/actuation and in the form of Pressurised inhalation suspension for oral inhalation.
ASTRAZENECA AG is the producer of SYMBICORT RAPIHALERª 160/4.5 mcg and it is imported from SWITZERLAND, The most popular alternatives of SYMBICORT RAPIHALERª 160/4.5 mcg are listed downward .
-
Active Substance
Budesonide/Formoterol
-
Size
120 Actuations
-
Indications
- No indications available.
-
Type
Pressurised inhalation suspension for oral inhalation
-
Company
ASTRAZENECA AG
Frequently Asked Questions
SYMBICORT RAPIHALERª 160/4.5 mcg should be stored according to the instructions provided by ASTRAZENECA AG.
In general, it is recommended to store SYMBICORT RAPIHALERª 160/4.5 mcg in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with SYMBICORT RAPIHALERª 160/4.5 mcg may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking SYMBICORT RAPIHALERª 160/4.5 mcg for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking SYMBICORT RAPIHALERª 160/4.5 mcg. Some medications, including
SYMBICORT RAPIHALERª 160/4.5 mcg, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of SYMBICORT RAPIHALERª 160/4.5 mcg, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking SYMBICORT RAPIHALERª 160/4.5 mcg without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking SYMBICORT RAPIHALERª 160/4.5 mcg if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of SYMBICORT RAPIHALERª 160/4.5 mcg during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 160/4.5 micrograms/actuation,
and the specific recommendations of ASTRAZENECA AG.
The effects of SYMBICORT RAPIHALERª 160/4.5 mcg on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 160/4.5 micrograms/actuation, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking SYMBICORT RAPIHALERª 160/4.5 mcg with or without food may vary depending on the medication
and the recommendations of ASTRAZENECA AG. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of SYMBICORT RAPIHALERª 160/4.5 mcg in children or elderly individuals may depend on various factors, including
the specific medication, type Pressurised inhalation suspension for oral inhalation, and the recommendations of ASTRAZENECA AG. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of SYMBICORT RAPIHALERª 160/4.5 mcg in children or elderly individuals.
0 Comments